The FDA has determined that<unk>  should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury, potentially leading to liver failure. When using to treat hyponatremia, it may cause too rapid correction of hyponatremia resulting in fatal osmotic demyelination syndrome.
Tolvaptan
Bumetanide
Amiloride
Paricalcitol
Mannitol
Dauricine
Torasemide
Azaperone